Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen

J Clin Oncol. 2002 Nov 1;20(21):4403. doi: 10.1200/JCO.2002.99.174.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Incidence
  • Mixed Tumor, Mullerian / chemically induced*
  • Mixed Tumor, Mullerian / epidemiology
  • Registries*
  • Risk Factors
  • Switzerland / epidemiology
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen